CN1423560A - 含炔诺酮的男用避孕制剂 - Google Patents

含炔诺酮的男用避孕制剂 Download PDF

Info

Publication number
CN1423560A
CN1423560A CN01808041A CN01808041A CN1423560A CN 1423560 A CN1423560 A CN 1423560A CN 01808041 A CN01808041 A CN 01808041A CN 01808041 A CN01808041 A CN 01808041A CN 1423560 A CN1423560 A CN 1423560A
Authority
CN
China
Prior art keywords
formulation
net
testosterone
androgen
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN01808041A
Other languages
English (en)
Chinese (zh)
Inventor
E·尼斯崎拉格
A·卡米斯奇科
M·奥伊特
A·鲁伊比格
E·施林格
U·－F·哈贝尼奇特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of CN1423560A publication Critical patent/CN1423560A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CN01808041A 2000-02-15 2001-02-15 含炔诺酮的男用避孕制剂 Pending CN1423560A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US50372900A 2000-02-15 2000-02-15
EP00200493 2000-02-15
US09/503,729 2000-02-15
EP00200493.5 2000-02-15

Publications (1)

Publication Number Publication Date
CN1423560A true CN1423560A (zh) 2003-06-11

Family

ID=26071832

Family Applications (1)

Application Number Title Priority Date Filing Date
CN01808041A Pending CN1423560A (zh) 2000-02-15 2001-02-15 含炔诺酮的男用避孕制剂

Country Status (26)

Country Link
EP (2) EP1267885B8 (enExample)
JP (1) JP2003522795A (enExample)
KR (1) KR20020086905A (enExample)
CN (1) CN1423560A (enExample)
AT (2) ATE355844T1 (enExample)
AU (1) AU2001230447A1 (enExample)
BG (1) BG107066A (enExample)
BR (1) BR0108411A (enExample)
CA (1) CA2398063A1 (enExample)
CY (1) CY1106639T1 (enExample)
CZ (1) CZ20022691A3 (enExample)
DE (2) DE60127103T2 (enExample)
DK (1) DK1267885T3 (enExample)
EE (1) EE200200454A (enExample)
ES (1) ES2282230T3 (enExample)
HK (1) HK1049442B (enExample)
HU (1) HUP0300128A3 (enExample)
IL (1) IL151219A0 (enExample)
MX (1) MXPA02007675A (enExample)
NO (1) NO20023607L (enExample)
PL (1) PL357185A1 (enExample)
PT (1) PT1267885E (enExample)
RU (1) RU2002124602A (enExample)
SI (1) SI1267885T1 (enExample)
SK (1) SK11602002A3 (enExample)
WO (1) WO2001060376A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101352443B (zh) * 2007-07-23 2011-01-12 中国科学院动物研究所 哺乳动物雄性不育剂

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10234525A1 (de) * 2002-07-25 2004-02-05 Schering Ag Zusammensetzung, enthaltend ein androgenes 11ß-Halogensteroid und ein Gestagen sowie männliches Kontrazeptivum auf Basis dieser Zusammensetzung
TW200404552A (en) * 2002-05-30 2004-04-01 Akzo Nobel Nv Self administered contraception
NZ549529A (en) 2002-07-24 2008-04-30 Schering Aktiengellschaft Microbiological processes for the production of 7alpha-substituted 11alpha-hydroxy steroids
WO2004011008A1 (de) * 2002-07-25 2004-02-05 Schering Aktiengesellschaft ZUSAMMENSETZUNG, ENTHALTEND EIN ANDROGENES 11β-HALOGENSTEROID UND EIN GESTAGEN SOWIE MÄNNLICHES KONTRAZEPTIVUM AUF BASIS DIESER ZUSAMMENSETZUNG
JO2505B1 (en) * 2003-03-14 2009-10-05 باير شيرنغ فارما اكتنجيسيلشافت Pharmacy methods and formulations for obtaining acceptable serum testosterone levels
KR102496504B1 (ko) 2018-03-23 2023-02-06 라보라뚜아르 마조르 남성 피임을 위한 비호르몬 조성물 및 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714420A1 (de) * 1976-06-01 1977-12-08 Int Pregnancy Advisory Service Antikonzeptionsmittel zur verabreichung an mann und frau in einer gemeinsamen verabreichungspackung
US4210644A (en) 1978-02-23 1980-07-01 The Johns Hopkins University Male contraception
US5035891A (en) 1987-10-05 1991-07-30 Syntex (U.S.A.) Inc. Controlled release subcutaneous implant
CN1102095A (zh) * 1993-10-30 1995-05-03 浙江医科大学 长效雄激素类制剂——十一酸睾丸注射液
DE19650352A1 (de) * 1996-12-04 1998-07-30 Jenapharm Gmbh Oral wirksames Kombinationspräparat zur Kontrazeption für den Mann

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101352443B (zh) * 2007-07-23 2011-01-12 中国科学院动物研究所 哺乳动物雄性不育剂

Also Published As

Publication number Publication date
CA2398063A1 (en) 2001-08-23
NO20023607L (no) 2002-10-15
JP2003522795A (ja) 2003-07-29
HK1049442B (en) 2007-06-15
EP1666044A1 (en) 2006-06-07
CZ20022691A3 (cs) 2003-01-15
AU2001230447A1 (en) 2001-08-27
MXPA02007675A (es) 2004-02-26
ATE474580T1 (de) 2010-08-15
EP1267885B8 (en) 2007-06-20
SI1267885T1 (sl) 2007-08-31
SK11602002A3 (sk) 2003-03-04
HUP0300128A3 (en) 2004-03-29
HK1049442A1 (en) 2003-05-16
WO2001060376A1 (en) 2001-08-23
ATE355844T1 (de) 2007-03-15
DE60127103T2 (de) 2007-11-22
EE200200454A (et) 2003-12-15
DE60127103D1 (de) 2007-04-19
PT1267885E (pt) 2007-05-31
DE60142647D1 (de) 2010-09-02
EP1267885B1 (en) 2007-03-07
BG107066A (en) 2003-05-30
DK1267885T3 (da) 2007-07-09
PL357185A1 (en) 2004-07-26
IL151219A0 (en) 2003-04-10
EP1666044B1 (en) 2010-07-21
KR20020086905A (ko) 2002-11-20
BR0108411A (pt) 2003-03-11
CY1106639T1 (el) 2012-01-25
NO20023607D0 (no) 2002-07-30
HUP0300128A2 (en) 2003-05-28
ES2282230T3 (es) 2007-10-16
EP1267885A1 (en) 2003-01-02
RU2002124602A (ru) 2004-03-10

Similar Documents

Publication Publication Date Title
US20060142257A1 (en) Male contraceptive formulation comprising norethisterone
CN1222292C (zh) 氟维司群制剂
US20040092494A9 (en) Method of increasing testosterone and related steroid concentrations in women
CN100349572C (zh) 提高妇女睾酮和相关类固醇浓度的方法
US7025979B2 (en) Male contraceptive formulation comprising norethisterone
US20040002482A1 (en) Androgen pharmaceutical composition and method for treating depression
JP4956185B2 (ja) 避妊及びホルモン補充療法用の調合製剤
JP2006516286A (ja) Ｓａｒｍによる女性のアンドロゲン減少に関連する病気の治療
PL219338B1 (pl) Preparat do podawania donosowego zawierający co najmniej jeden będący lekiem hormon płciowy wybrany spośród testosteronu, biologicznych proleków hormonu płciowego wybranych spośród androstendionu i progesteronu oraz ich połączeń, oraz dalsze składniki
US20110306582A1 (en) Androgen pharmaceutical composition and method for treating depression
EP4091601A1 (en) Gel compositions for transdermal delivery to maximize drug concentrations in the stratum corneum and serum and methods of use thereof
CN1671394A (zh) 包含雄激素性11β－卤素甾体和孕激素的组合物以及基于该组合物的雄性避孕药
JP2006505564A (ja) Ｓａｒｍによる高齢男性のアンドロゲン減少に関連する病気の治療
CN1423560A (zh) 含炔诺酮的男用避孕制剂
CA2484164C (en) Androgen pharmaceutical composition and method for treating depression
CN101332174A (zh) 二氢睾酮外用制剂及其药物用途
HK1090576A (en) Male contraceptive formulation comprising norethisterone
HK40083904A (en) Gel compositions for transdermal delivery to maximize drug concentrations in the stratum corneum and serum and methods of use thereof
RU2616252C2 (ru) Способ регулирования полового поведения самцов млекопитающих
HK1081847A (en) COMPOSITION CONTAINING AN ANDROGENOUS 11β-HALOGEN STEROID AND A PROGESTATIONAL HORMONE, AND MALE CONTRACEPTIVE BASED ON SAID COMPOSITION
HK1061804B (en) Method of increasing testosterone and related steroid concentrations in women
HK1098685A (en) Pharmaceutical preparation containing drospirenone for application to the skin

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication